Skip to content

Clinical trials

Phase 4 Coronary Artery Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 4 Country / region: United States Clear all

139 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20044
20053
20069
20074
20085
200915
20105
20115
201210
201311
201412
20157
20168
20171
20185
20196
20202
20216
20221
20236
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Unknown status13
Terminated12
Recruiting10
Withdrawn9
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Florida26
NYU Langone Health6
Massachusetts General Hospital5
Boston Scientific Corporation4
LifeBridge Health4
Cedars-Sinai Medical Center3
Daiichi Sankyo3
Johns Hopkins University3
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center3
VA Office of Research and Development3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease139
Diabetes Mellitus12
Atherosclerosis10
Myocardial Ischemia10
Cardiovascular Diseases9
Coronary Disease8
Diabetes Mellitus, Type 27
Heart Diseases7
Hypertension7
Acute Coronary Syndrome6

Trials

Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.

39 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.